UPDATE: Morgan Stanley Starts Bolt Biotherapeutics, Inc. (BOLT) at Overweight on Innovative ISAC Technology
Tweet Send to a Friend
(Updated - March 2, 2021 7:17 AM EST)
Morgan Stanley analyst Matthew Harrison initiates coverage on Bolt Biotherapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison initiates coverage on Bolt Biotherapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
